Gufic BioSciences receives ratings action from ICRA

Image
Capital Market
Last Updated : Mar 06 2021 | 10:04 AM IST
Gufic BioSciences announced that ICRA has assigned the following credit ratings taking into consideration the impending Scheme of Amalgamation of Gufic Lifesciences with the Company and their respective shareholders and creditors.

Long term fund based working capital - ICRA BBB; Stable (assigned)
Short term letter of credit - ICRA A3+ (assigned)
Short term bank guarantee - ICRA A3+ (assigned)

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Mar 06 2021 | 9:44 AM IST

Next Story